Skip to main content
Erschienen in: International Urogynecology Journal 5/2018

13.07.2017 | Original Article

Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition

verfasst von: Gery Lamblin, Capucine Meysonnier, Stéphanie Moret, Béatrice Nadaud, Georges Mellier, Gautier Chene

Erschienen in: International Urogynecology Journal | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The objective was to evaluate the surgical feasibility of opportunistic salpingectomy or salpingo-oophorectomy during benign vaginal hysterectomy (HV) and the prevalence of occult tubal lesions.

Methods

In this prospective study from 1 September 2013 to 1 November 2015, the prevalence of bilateral salpingectomy with or without ovariectomy and the prevalence of histopathological and immunohistochemical tubal abnormalities were assessed.

Results

A total 115 patients were included. Bilateral salpingectomy was performed in 85 patients (73.92%; group A) and was technically impossible in 30 patients (26.08%; group B). Older patients (62.9 vs 57.5 years, p = 0.009), menopausal status (83.33% vs 62.35%, p = 0.03) and elevated BMI (27.58 vs 25.05 p = 0.03) were statistically associated with failure of salpingectomy. There was only one case of postoperative hemorrhage in group A. There was no difference with regard to intra- or postoperative complications, blood loss, and operating time between the two groups. Among the 67 fallopian tubes analyzed with a validated histopathological protocol, there were 8 (11.94%) immunohistochemical abnormalities with a “p53 signature.”

Conclusions

With the recent demonstration of a tubal origin of most ovarian cancer, opportunistic salpingectomy could be a theoretically relevant prevention strategy. Bilateral salpingectomy could be performed during benign vaginal hysterectomy by experienced surgeons. The advantages and disadvantages of exclusive salpingectomy during pelvic floor surgery should be discussed with the patients.
Literatur
1.
Zurück zum Zitat Chene G, Rahimi K, Mes-Masson AM, Provencher D. Surgical implications of the potential new tubal pathway for ovarian carcinogenesis. J Minim Invasive Gynecol. 2013;20:153–9.CrossRefPubMed Chene G, Rahimi K, Mes-Masson AM, Provencher D. Surgical implications of the potential new tubal pathway for ovarian carcinogenesis. J Minim Invasive Gynecol. 2013;20:153–9.CrossRefPubMed
2.
Zurück zum Zitat Oliver Perez MR, Magrina J, Garcia AT, Jimenez Lopez JS. Prophylactic salpingectomy and prophylactic salpingooophorectomy for adnexal high-grade serous epithelial carcinoma: a reappraisal. Surg Oncol. 2015;24:335–44.CrossRefPubMed Oliver Perez MR, Magrina J, Garcia AT, Jimenez Lopez JS. Prophylactic salpingectomy and prophylactic salpingooophorectomy for adnexal high-grade serous epithelial carcinoma: a reappraisal. Surg Oncol. 2015;24:335–44.CrossRefPubMed
3.
Zurück zum Zitat Walker JL, Powell CB, Chen LM, Carter J, Bae Jump VL, Parker LP, et al. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer. 2015;121:2108–20. Walker JL, Powell CB, Chen LM, Carter J, Bae Jump VL, Parker LP, et al. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer. 2015;121:2108–20.
4.
Zurück zum Zitat Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30:230–6.CrossRefPubMed Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30:230–6.CrossRefPubMed
5.
Zurück zum Zitat Chene G, Meysonnier C, Buenerd A, Moret S, Beaufils E, Le Bail-Carval K, et al. Feasibility of opportunistic salpingectomy at the time of vaginal hysterectomy for benign pathology and evaluation of occult tubal lesions prevalence: preliminary study. J Gynecol Obstet Biol Reprod (Paris). 2016;45:549–58. Chene G, Meysonnier C, Buenerd A, Moret S, Beaufils E, Le Bail-Carval K, et al. Feasibility of opportunistic salpingectomy at the time of vaginal hysterectomy for benign pathology and evaluation of occult tubal lesions prevalence: preliminary study. J Gynecol Obstet Biol Reprod (Paris). 2016;45:549–58.
6.
Zurück zum Zitat Davies A, O’Connor H, Magos AL. A prospective study to evaluate oophorectomy at the time of vaginal hysterectomy. Br J Obstet Gynaecol. 1996;103:915–20.CrossRefPubMed Davies A, O’Connor H, Magos AL. A prospective study to evaluate oophorectomy at the time of vaginal hysterectomy. Br J Obstet Gynaecol. 1996;103:915–20.CrossRefPubMed
7.
Zurück zum Zitat Kovac SR, Barhan S, Lister M, Tucker L, Bishop M, Das A. Guidelines for the selection of the route of hysterectomy : application in a resident clinic population. Am J Obstet Gynecol. 2002;187:1521–7.CrossRefPubMed Kovac SR, Barhan S, Lister M, Tucker L, Bishop M, Das A. Guidelines for the selection of the route of hysterectomy : application in a resident clinic population. Am J Obstet Gynecol. 2002;187:1521–7.CrossRefPubMed
8.
Zurück zum Zitat Muller CY, Coleman RL, Toler K, Gibbons D, Ashfaq R, Voet RL. Adequacy of oophorectomy at the time of gynecologic surgery. Int J Gynaecol Obstet. 2002;77:23–9.CrossRefPubMed Muller CY, Coleman RL, Toler K, Gibbons D, Ashfaq R, Voet RL. Adequacy of oophorectomy at the time of gynecologic surgery. Int J Gynaecol Obstet. 2002;77:23–9.CrossRefPubMed
9.
Zurück zum Zitat Bogani G, Cromi A, Serati M, Di Naro E, Casarin J, Pinelli C, et al. Laparoscopic and vaginal approaches to hysterectomy in the obese. Eur J Obstet Gynecol Reprod Biol. 2015;189:85–90. Bogani G, Cromi A, Serati M, Di Naro E, Casarin J, Pinelli C, et al. Laparoscopic and vaginal approaches to hysterectomy in the obese. Eur J Obstet Gynecol Reprod Biol. 2015;189:85–90.
10.
Zurück zum Zitat Karp DR, Mukati M, Smith AL, Suciu G, Aguilar VC, Davila GW. Predictors of successful salpingo-oophorectomy at the time of vaginal hysterectomy. J Minim Invasive Gynecol. 2012;19:58–62.CrossRefPubMed Karp DR, Mukati M, Smith AL, Suciu G, Aguilar VC, Davila GW. Predictors of successful salpingo-oophorectomy at the time of vaginal hysterectomy. J Minim Invasive Gynecol. 2012;19:58–62.CrossRefPubMed
11.
Zurück zum Zitat Cho HY, Kang SW, Kim HB, Park SH, Park ST. Prophylactic adnexectomy along with vaginal hysterectomy for benign pathology. Arch Gynecol Obstet. 2012;286:1221–5.CrossRefPubMed Cho HY, Kang SW, Kim HB, Park SH, Park ST. Prophylactic adnexectomy along with vaginal hysterectomy for benign pathology. Arch Gynecol Obstet. 2012;286:1221–5.CrossRefPubMed
12.
Zurück zum Zitat Sheth SS. Adnexectomy for benign pathology at vaginal hysterectomy without laparoscopic assistance. Br J Obstet Gynaecol. 2002;109:1401–5.CrossRef Sheth SS. Adnexectomy for benign pathology at vaginal hysterectomy without laparoscopic assistance. Br J Obstet Gynaecol. 2002;109:1401–5.CrossRef
13.
Zurück zum Zitat Robert M, Cenaiko D, Sepandj J, Iwanicki S. Success and complications of salpingectomy at the time of vaginal hysterectomy. J Minim Invasive Gynecol. 2015;22:864–9.CrossRefPubMed Robert M, Cenaiko D, Sepandj J, Iwanicki S. Success and complications of salpingectomy at the time of vaginal hysterectomy. J Minim Invasive Gynecol. 2015;22:864–9.CrossRefPubMed
14.
Zurück zum Zitat Chene G, de Rochambeau B, Le Bail-Carval K, Beaufils E, Chabert P, Mellier G, et al. Current surgical practice of prophylactic and opportunistic salpingectomy in France. Gynecol Obstet Fertil. 2016;44:377–84. Chene G, de Rochambeau B, Le Bail-Carval K, Beaufils E, Chabert P, Mellier G, et al. Current surgical practice of prophylactic and opportunistic salpingectomy in France. Gynecol Obstet Fertil. 2016;44:377–84.
15.
Zurück zum Zitat Rabban JT, Garg K, Crawford B, Chen LM, Zaloudek CJ. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery. Am J Surg Pathol. 2014;38:729–42.CrossRefPubMed Rabban JT, Garg K, Crawford B, Chen LM, Zaloudek CJ. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery. Am J Surg Pathol. 2014;38:729–42.CrossRefPubMed
16.
Zurück zum Zitat Mehrad M, Ning G, Chen EY, Mehra KK, Crum CP. A pathologist’s road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube. Adv Anat Pathol. 2010;17:293–302.CrossRefPubMed Mehrad M, Ning G, Chen EY, Mehra KK, Crum CP. A pathologist’s road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube. Adv Anat Pathol. 2010;17:293–302.CrossRefPubMed
17.
Zurück zum Zitat McAlpine JN, Hanley GE, Woo MM, Tone AA, Rozenberg N, Swenerton KD, et al. Ovarian cancer research program of British Columbia. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. Am J Obstet Gynecol. 2014;210:471.e1–11. McAlpine JN, Hanley GE, Woo MM, Tone AA, Rozenberg N, Swenerton KD, et al. Ovarian cancer research program of British Columbia. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. Am J Obstet Gynecol. 2014;210:471.e1–11.
18.
Zurück zum Zitat Kapurubandara S, Qin V, Gurram D, Anpalagan A, Merkur H, Hogg R, et al. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: a survey of current Australian practice. Aust NZ J Obstet Gynaecol. 2015;55:606–11. Kapurubandara S, Qin V, Gurram D, Anpalagan A, Merkur H, Hogg R, et al. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: a survey of current Australian practice. Aust NZ J Obstet Gynaecol. 2015;55:606–11.
19.
Zurück zum Zitat Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy and long term health outcomes in the nurses health study. Obstet Gynecol. 2010;113:1027–37.CrossRef Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy and long term health outcomes in the nurses health study. Obstet Gynecol. 2010;113:1027–37.CrossRef
20.
Zurück zum Zitat Dwyer PL. Ovarian cancer and the pelvic floor surgeon: the case for prophylactic bilateral salpingectomy during POP surgery. Int Urogynecol J. 2012;23:655–6.CrossRefPubMed Dwyer PL. Ovarian cancer and the pelvic floor surgeon: the case for prophylactic bilateral salpingectomy during POP surgery. Int Urogynecol J. 2012;23:655–6.CrossRefPubMed
21.
Zurück zum Zitat Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005;106:219–26.CrossRefPubMed Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005;106:219–26.CrossRefPubMed
22.
Zurück zum Zitat Chene G, Lamblin G, Marcelli M, Huet S, Gauthier T. Urinary, infectious and digestive adverse events related to benign hysterectomy and the associated surgery on the fallopian tube: guidelines. J Gynecol Obstet Biol Reprod. 2015;44:1183–205.CrossRef Chene G, Lamblin G, Marcelli M, Huet S, Gauthier T. Urinary, infectious and digestive adverse events related to benign hysterectomy and the associated surgery on the fallopian tube: guidelines. J Gynecol Obstet Biol Reprod. 2015;44:1183–205.CrossRef
23.
Zurück zum Zitat Repasy I, Lendvai V, Koppan A, Bodis J, Koppan M. Effect of the removal of the fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2009;144:64–7.CrossRefPubMed Repasy I, Lendvai V, Koppan A, Bodis J, Koppan M. Effect of the removal of the fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2009;144:64–7.CrossRefPubMed
24.
Zurück zum Zitat Ghezzi F, Cromi A, Siesto G, Bergamini V, Zefiro F, Bolis P. Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference? BJOG. 2009;116:589–93.CrossRefPubMed Ghezzi F, Cromi A, Siesto G, Bergamini V, Zefiro F, Bolis P. Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference? BJOG. 2009;116:589–93.CrossRefPubMed
25.
Zurück zum Zitat Morse AN, Hammer RA, Walter AJ, Baker S, Magtibay PM. Does hysterectomy without adnexectomy in patients with prior tubal interruption increase the risk of subsequent hydrosalpinx? Am J Obstet Gynecol. 2002;187:1483–6.CrossRefPubMed Morse AN, Hammer RA, Walter AJ, Baker S, Magtibay PM. Does hysterectomy without adnexectomy in patients with prior tubal interruption increase the risk of subsequent hydrosalpinx? Am J Obstet Gynecol. 2002;187:1483–6.CrossRefPubMed
26.
Zurück zum Zitat Vorwerg J, Radosa MP, Nicolaus K, Baus N, Jimenez Cruz J, Rengsberger M, et al. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and reoperation rate. J Cancer Res Clin Oncol. 2014;140:859–65. Vorwerg J, Radosa MP, Nicolaus K, Baus N, Jimenez Cruz J, Rengsberger M, et al. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and reoperation rate. J Cancer Res Clin Oncol. 2014;140:859–65.
27.
Zurück zum Zitat Venturella R, Lico D, Borelli M, Imbrogno MG, Cevenini G, Zupi E, et al. 3 to 5 years later: long-term effects of prophylactic bilateral salpingectomy on ovarian function. J Minim Invasive Gynecol. 2017;24:145–50. Venturella R, Lico D, Borelli M, Imbrogno MG, Cevenini G, Zupi E, et al. 3 to 5 years later: long-term effects of prophylactic bilateral salpingectomy on ovarian function. J Minim Invasive Gynecol. 2017;24:145–50.
28.
Zurück zum Zitat Yoon SH, Kim SN, Shim SH, Kang SB, Lee SJ. Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis. Eur J Cancer. 2016;55:38–46.CrossRefPubMed Yoon SH, Kim SN, Shim SH, Kang SB, Lee SJ. Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis. Eur J Cancer. 2016;55:38–46.CrossRefPubMed
29.
Zurück zum Zitat Darelius A, Lycke M, Kindblom JM, Kristjansdottir B, Sundfeldt K, Strandell A. Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review. BJOG. 2017;124:880–9.CrossRefPubMed Darelius A, Lycke M, Kindblom JM, Kristjansdottir B, Sundfeldt K, Strandell A. Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review. BJOG. 2017;124:880–9.CrossRefPubMed
Metadaten
Titel
Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition
verfasst von
Gery Lamblin
Capucine Meysonnier
Stéphanie Moret
Béatrice Nadaud
Georges Mellier
Gautier Chene
Publikationsdatum
13.07.2017
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 5/2018
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-017-3418-0

Weitere Artikel der Ausgabe 5/2018

International Urogynecology Journal 5/2018 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.